The US AI Drug Discovery Market is on a trajectory to reach an astonishing $2,494.89 million by 2035, showcasing a remarkable compound annual growth rate (CAGR) of 25.15%. This explosive growth is underpinned by significant investments and increasing collaborations among pharmaceutical companies and tech firms. As organizations seek innovative solutions to streamline their drug development...